RemeGen Co., Ltd. (REGMF) Financials

REGMF Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 1.0 billion 507.7 million
Sept. 30, 2025 839.2 million 513.5 million
June 30, 2025 816.6 million 487.6 million
March 31, 2025 730.7 million 486.8 million

REGMF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 -26.3 million ?
Sept. 30, 2025 56.8 million ?
June 30, 2025 -19.8 million 1.7 million
March 31, 2025 -30.8 million ?

REGMF Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
Dec. 31, 2025 177.5 million
Sept. 30, 2025 -14.2 million
June 30, 2025 -27.3 million
March 31, 2025 -35.0 million

REGMF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 346.4 million 104.7 million 2.8 million
Sept. 30, 2025 165.6 million 97.7 million 3.5 million
June 30, 2025 179.1 million 114.0 million 9.8 million
March 31, 2025 99.4 million 146.4 million 4.7 million

REGMF Shares Outstanding

No data available :(

REGMF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 3.6 million - - -
Sept. 30, 2025 7.9 million 34.2 million 52.2 million -
June 30, 2025 11.9 million 44.4 million 46.6 million 38.4 million
March 31, 2025 4.9 million 45.3 million 46.3 million 34.5 million

REGMF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 215.6 million 27.4 million
Sept. 30, 2025 86.7 million 13.4 million
June 30, 2025 79.8 million 12.1 million
March 31, 2025 72.4 million 12.1 million

REGMF

Price: $12.05

52 week price:
5.06
12.85

Earnings Per Share: 0.19 USD

P/E Ratio: 57.63

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 6.8 billion

Links: